Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 5A, mitochondrial (COX5A), is a nuclear-encoded subunit of cytochrome c oxidase (Complex IV), the terminal enzyme of the mitochondrial respiratory chain. The protein is located in the inner mitochondrial membrane, where it is essential for oxidative phosphorylation, facilitating the transfer of electrons from cytochrome c to molecular oxygen, enabling ATP synthesis and maintaining cellular energy. COX5A is implicated in the regulation, assembly, and stability of the enzyme complex. Defects or altered expression of COX5A are associated with complex IV deficiency diseases, neurodegenerative disorders such as Alzheimer’s disease, and altered cell metabolism in cancer. Experimental data suggest COX5A influences neuronal plasticity and is a candidate therapeutic target for conditions of mitochondrial dysfunction
Enzyme inhibition (general for cytochrome c oxidase complex: disruption of electron transfer and ATP synthesis), experimental modulation (possibly via gene expression changes affecting mitochondrial function)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 5A, mitochondrial (COX5A).